2022. Effect of non-nucleoside reverse transcriptase inhibitors and protease inhibitors on serum levels of myeloperoxidase and C-reactive protein in HIV-infected individuals. Brazilian Journal of Pharmaceutical Sciences. 58, (Dec. 2022). DOI:https://doi.org/10.1590/s2175-97902020000118780 .